Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Must Reads In FDA Actions
FDA Actions for March/April 2019
FDA Approves Gloperba Oral Solution for Gout Flares, FirstWord Pharma news release; 2019 Feb 26
FDA Actions for November/December 2018
FDA Approves Hyrimoz for Chronic Conditions, Sandoz news release; 2018 Oct 31
FDA Actions for September/October 2018
FDA Approves Subcutaneous Actemra for Active SJIA, PharmaLive news release; 2018 Sep 13
FDA Actions for July/August 2018
FDA Approves Olumiant for Rheumatoid Arthritis, Eli Lilly, Incyte news release; 2018 Jun 1
FDA Actions for May/June 2018
FDA Approves Consensi for Osteoarthritis Pain, FirstWord Pharma news release; 2018 May 31
FDA Approves Prolia for GIOP in Men and Women, FirstWord Pharma news release; 2018 May 21